Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Aclarion, Inc. develops non-invasive diagnostic technology using Magnetic Resonance Spectroscopy (MRS) and proprietary biomarkers to identify painful intervertebral discs causing chronic low back and neck pain. Its flagship product, NOCISCAN®, enhances standard MRI scans by chemically analyzing disc tissue to guide treatment decisions, primarily for spine surgeons and imaging centers. The company’s software-driven platform aims to improve patient outcomes and reduce healthcare costs in the large, costly back pain market.
This description was generated via AI from an annual report. Updated about 1 year ago.